Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
Genome Medicine|August 15, 2022
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patientsOzge Ceyhan-Birsoy, Gowtham Jayakumaran, Yelena Kemel, et al.
Plos Genetics|January 26, 2013
Susceptibility loci associated with specific and shared subtypes of lymphoid malignanciesJoseph Vijai, Tomas Kirchhoff, Kasmintan A Schrader, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2013
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study reportJonine L Bernstein, Duncan C Thomas, Roy E Shore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response DefectsSami Belhadj, Aliya Khurram, Chaitanya Bandlamudi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 VariantKasmintan A Schrader, Kelly L Stratton, Rajmohan Murali, et al.
JCO Global Oncology|October 26, 2023
Biospecimen Repositories in Low- and Middle-Income Countries: Insights From an American University of Beirut and Memorial Sloan Kettering CollaborationWalid Faraj, Mark Robson, Ayman Tawil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
Nature|January 8, 2025
Functional evaluation and clinical classification of BRCA2 variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Genome Medicine|August 15, 2022
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patientsOzge Ceyhan-Birsoy, Gowtham Jayakumaran, Yelena Kemel, et al.
Plos Genetics|January 26, 2013
Susceptibility loci associated with specific and shared subtypes of lymphoid malignanciesJoseph Vijai, Tomas Kirchhoff, Kasmintan A Schrader, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 MutationsMarjorie G Zauderer, Gowtham Jayakumaran, Mariel DuBoff, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2013
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study reportJonine L Bernstein, Duncan C Thomas, Roy E Shore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response DefectsSami Belhadj, Aliya Khurram, Chaitanya Bandlamudi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 VariantKasmintan A Schrader, Kelly L Stratton, Rajmohan Murali, et al.
JCO Global Oncology|October 26, 2023
Biospecimen Repositories in Low- and Middle-Income Countries: Insights From an American University of Beirut and Memorial Sloan Kettering CollaborationWalid Faraj, Mark Robson, Ayman Tawil, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
Nature|January 8, 2025
Functional evaluation and clinical classification of BRCA2 variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Pageof 22